Catalent (CTLT) Stock Pops 10% on Sale to Novo Nordisk

Catalent (NYSE:CTLT) stock is climbing higher on Monday after the company agreed to sell itself to Novo Nordisk (NYSE:NVO) parent Novo Holdings for $16.5 billion.The transaction will have Novo Holdings paying$63.50 per share in cash for CTLT stock. That represents a premium of 16.5% over the closing price for Catalent’s stock on Friday. It’s also a 47.5% premium to the 60-day volume-weighted average price of the shares.After the deal closes, Novo Holdings intends to sell three of Catalent’s 60 locations to ...